|
|
 Impact Information - September 8, 2008
| A New Jersey-based drug manufacturer has issued a retail and pharmacy-level drug recall for 65 different drugs after the manufacturing facility failed a Food and Drug Administration (FDA) inspection. The inspection at the Little Falls, N.J., facility of Actavis Totowa LLC did not meet the FDA's or Actavis' standards for good manufacturing practices, the company said in a statement. However, consumers are not being asked to return the drugs and should continue their medications until told otherwise by a doctor | | An anticipated rise in health problems among Canadians, caused by climate change, has motivated Health Canada to urge the government to take immediate action. In a 500-page report released Friday, the health agency forecasts more incidents of heat-related ailments, deaths due to outbreaks of infectious diseases unknown to the medical community, respiratory and cardiovascular disorders | | Several popular laundry products and air fresheners may contain toxic chemicals, including some regulated as toxic or hazardous under federal law, according to a new study. Researchers from University of Washington analyzed a range of top-selling products from plug-in oils to dryer sheets, fabric softeners and detergents. The results indicated that these products contained at least one chemical which was deemed toxic or hazardous | | A 23-year-old man from New Delhi who was admitted to an Indian hospital after a five-feet-long iron rod went through his chest has survived the accident. Calling it the "rarest of the rare surgeries," doctors of the All India Institute of Medical Sciences (AIIMS) saved the life of a young executive, Supratim Dutta, whose chest, lungs, stomach and liver were pierced by an iron bar | | California researchers say they have developed molecule-sized "hypodermics" called nanoparticles that deliver drug agents to stop pancreatic and kidney cancer from spreading in mice but have fewer side effects than traditional chemotherapy. A team from the University of California San Diego (UCSD), say that because the nanoparticles target only the cells causing the tumor, such drugs could make for smaller, safer doses for treating cancer growth | |
|
|